Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebif Once Weekly in CIS
NCT00287079Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Oct 2005
- Primary completion
- Nov 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon beta-1a in clinically isolated syndrome (CIS), sponsored by Merck KGaA. Started Oct 2005; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT00287079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287079.